Terao Mineko, Romão Maria João, Leimkühler Silke, Bolis Marco, Fratelli Maddalena, Coelho Catarina, Santos-Silva Teresa, Garattini Enrico
Laboratory of Molecular Biology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", via La Masa 19, 20156, Milan, Italy.
UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 32829-516, Caparica, Lisbon, Portugal.
Arch Toxicol. 2016 Apr;90(4):753-80. doi: 10.1007/s00204-016-1683-1. Epub 2016 Feb 26.
Mammalian aldehyde oxidases (AOXs; EC1.2.3.1) are a group of conserved proteins belonging to the family of molybdo-flavoenzymes along with the structurally related xanthine dehydrogenase enzyme. AOXs are characterized by broad substrate specificity, oxidizing not only aromatic and aliphatic aldehydes into the corresponding carboxylic acids, but also hydroxylating a series of heteroaromatic rings. The number of AOX isoenzymes expressed in different vertebrate species is variable. The two extremes are represented by humans, which express a single enzyme (AOX1) in many organs and mice or rats which are characterized by tissue-specific expression of four isoforms (AOX1, AOX2, AOX3, and AOX4). In vertebrates each AOX isoenzyme is the product of a distinct gene consisting of 35 highly conserved exons. The extant species-specific complement of AOX isoenzymes is the result of a complex evolutionary process consisting of a first phase characterized by a series of asynchronous gene duplications and a second phase where the pseudogenization and gene deletion events prevail. In the last few years remarkable advances in the elucidation of the structural characteristics and the catalytic mechanisms of mammalian AOXs have been made thanks to the successful crystallization of human AOX1 and mouse AOX3. Much less is known about the physiological function and physiological substrates of human AOX1 and other mammalian AOX isoenzymes, although the importance of these proteins in xenobiotic metabolism is fairly well established and their relevance in drug development is increasing. This review article provides an overview and a discussion of the current knowledge on mammalian AOX.
哺乳动物醛氧化酶(AOXs;EC1.2.3.1)是一组保守蛋白,与结构相关的黄嘌呤脱氢酶同属于钼黄素酶家族。AOXs的特点是底物特异性广泛,不仅能将芳香族和脂肪族醛氧化为相应的羧酸,还能使一系列杂芳环羟基化。不同脊椎动物物种中表达的AOX同工酶数量各不相同。两个极端情况分别是人类,在许多器官中只表达一种酶(AOX1),以及小鼠或大鼠,其特点是四种同工型(AOX1、AOX2、AOX3和AOX4)呈组织特异性表达。在脊椎动物中,每种AOX同工酶都是一个由35个高度保守外显子组成的独特基因的产物。现存的物种特异性AOX同工酶组合是一个复杂进化过程的结果,该过程包括以一系列异步基因复制为特征的第一阶段和以假基因化和基因缺失事件为主的第二阶段。在过去几年中,由于成功解析了人AOX1和小鼠AOX3的晶体结构,在阐明哺乳动物AOXs的结构特征和催化机制方面取得了显著进展。尽管这些蛋白在异源物质代谢中的重要性已得到充分证实,且它们在药物开发中的相关性也在增加,但对于人AOX1和其他哺乳动物AOX同工酶的生理功能和生理底物却知之甚少。本文综述了关于哺乳动物AOX的现有知识并进行了讨论。